Although the exposure of 4T1 mouse BC cells to recombinant IL-17 had little effect on cancer cell proliferation in vitro, administration of this cytokine to cancer mice significantly increased tumor size, associated with increased angiogenesis. This evidence concerns the gene IL17A and cancer.